Clinical Trial

Relationship Between Remimazolam and Etomidate in Induction of General Anesthesia

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 10, 2025 (before its estimated June 19, 2025 completion). Its status may not reflect the trial's current state.
Summary
In modern anesthesia practice, anesthesiologists often need to choose a combination of multiple drugs according to the specific conditions and surgical needs of patients, which can not only achieve more fine anesthesia management, but also improve perioperative safety and patient comfort. In clinical practice, anesthesiologists will use etomidate combined with a small dose of remimazolam for anesthesia induction to obtain more stable hemodynamics, prevent intraoperative awareness, and relieve anxiety.However, what is the best dose ratio of etomidate combined with remimazolam, the current literature does not give clear indicators.
Trial Details
NCT Number NCT07012902
Lead Sponsor Second Hospital of Shanxi Medical University
Conditions Induction Anesthesia, Drug Interactions
Enrollment 125 participants
Start Date 2025-06-12
Primary Completion 2025-06-19 (estimated)
Study Completion 2025-07-19 (estimated)
Updated on ClinicalTrials.gov 2025-06-10